Indian Drug Makers Thrive With Focus On Catering To Poor Countries
This article was originally published in PharmAsia News
Executive Summary
Despite its relatively poor health care, India is seeing its pharmaceutical companies growing at a fast rate as they produce innovative drugs needed in poorer companies. Troikaa Pharmaceuticals is ready to launch its injectible Dynapar AQ in smaller, more-affordable doses and in poorer countries in Africa, Latin America, former Soviet republics and the European Union. Sami Labs focuses on its herb-based Ayurveda, which makes available a psoriasis treatment at only 10 percent of the cost of chemical-based drugs for the ailment. (Click here for more